BridgeBio is demonstrably improved this course of a new treatment for ATTR-CM, utilizing the compound. Preliminary trial information suggests significant improvements for those diagnosed by this debilitating disease. https://biotech511018.blog5star.com/42519999/firm-improves-amyloidosis-therapy-using-attruby